Clexane and Prolia drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clexane (enoxaparin sodium) and Prolia (denosumab). Common drug interactions include musculoskeletal stiffness among females and depression among males.

The phase IV clinical study analyzes what interactions people have when they take Clexane and Prolia. It is created by eHealthMe based on reports of 90 people who take the same drugs from the FDA, and is updated regularly.

What is Clexane?

Clexane has active ingredients of enoxaparin sodium. eHealthMe is studying from 14,679 Clexane users. Check the latest studies of Clexane.

What is Prolia?

Prolia has active ingredients of denosumab. It is often used in osteoporosis. eHealthMe is studying from 151,388 Prolia users. Check the latest studies of Prolia.



On Jul, 15, 2026

90 people who take Clexane and Prolia together, and have interactions are studied.

Clexane and Prolia drug interactions.

What are the common drug interactions of Clexane and Prolia, by gender? *:

female:

  1. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  2. Neuropathy peripheral (surface nerve damage)
  3. Non-cardiac chest pain
  4. Oral candidiasis (fungal infection of mouth)
  5. Oropharyngeal pain
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Productive cough
  8. Pulmonary thrombosis (scarring in the lungs)
  9. Rash
  10. Rash macular (small, flat red spots)

male:

  1. Depression
  2. Erysipelas (bacterial skin infection)
  3. Platelet count decreased
  4. Prostate cancer
  5. Rash erythematous (redness of the skin)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Suture rupture
  8. Venous thrombosis limb (blood clot that forms in a vein in the limb)
  9. Soft tissue disorder (disease of soft tissue)
  10. Leukopenia (less number of white blood cells in blood)

What are the common drug interactions of Clexane and Prolia, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Pancreatitis (inflammation of pancreas)

10-19:

n/a

20-29:

n/a

30-39:

  1. Antepartum haemorrhage (bleeding from the vagina during pregnancy from the 24th week)
  2. Blood calcium decreased
  3. Blood parathyroid hormone increased
  4. Blood pressure diastolic increased
  5. Foetal distress syndrome (altered heart rate or rhythm and leading tocompromised blood flow or changes in blood chemistry of foetus)
  6. Foetal growth restriction (poor growth of a baby while in the mother's womb during pregnancy)
  7. Gestational trophoblastic detachment (impaired connection of surrounding layer of foetus nutrition supplying cells in pregnancy)
  8. Maternal exposure during pregnancy (use of substance during pregnancy)
  9. Mitral valve disease (disease of mitral valve of heart)
  10. Oligohydramnios (a condition in pregnancy characterized by a deficiency of amniotic fluid)

40-49:

  1. Abdominal pain
  2. Influenza like illness
  3. Portal vein thrombosis (venous thrombosis affecting the hepatic portal vein)

50-59:

  1. Chest discomfort
  2. Chest pain
  3. Confusional state
  4. Constipation
  5. Cough
  6. Decreased appetite
  7. Diarrhoea
  8. Dry mouth
  9. Dry skin
  10. Dysgeusia (disorder of the sense of taste)

60+:

  1. Fall
  2. Impaired healing
  3. Lymphoedema (localized fluid retention and tissue swelling)
  4. Platelet count decreased
  5. Prostate cancer
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Suture rupture
  8. Venous thrombosis limb (blood clot that forms in a vein in the limb)
  9. Soft tissue disorder (disease of soft tissue)
  10. Leukopenia (less number of white blood cells in blood)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 49 people, 54.44%
  2. Vasculitis (inflammation of a blood vessel or blood vessels): 48 people, 53.33%
  3. Venous Thrombosis Limb (blood clot that forms in a vein in the limb): 45 people, 50.00%
  4. Muscle Aches (muscle pain): 45 people, 50.00%
  5. Temporal Arteritis (inflammation and damage to blood vessels that supply the head area): 15 people, 16.67%
  6. High Blood Pressure: 6 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Clexane and Prolia?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clexane and Prolia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clexane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prolia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clexane and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prolia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on enoxaparin sodium and denosumab (the active ingredients of Clexane and Prolia, respectively), and Clexane and Prolia (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: